We are live on ! Find out more
FLGT icon

Fulgent Genetics
FLGT

Fund managers haven’t disclosed any holdings of FLGT yet.

FLGT Hedge Fund Activity: Q1 2026 in Review

157 of the 8,133 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2026, worth a combined $277M — down 41% from $469M a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of FLGT and 29 opened new positions — a net loss of 17 holders — while 54 trimmed existing stakes and 49 added.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $13.2M. The largest seller was Millennium Management, cutting an estimated $11.7M.

  • 157 institutional investors held Fulgent Genetics (FLGT) as of Q1 2026, down from 179 in Q4 2025.
  • Funds reported $277M of Fulgent Genetics stock for Q1 2026, down 41% quarter-over-quarter.
  • 29 funds opened new Fulgent Genetics positions in Q1 2026 and 46 closed out, a net change of -17 holders.
  • The largest Fulgent Genetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $13.2M added.
  • The largest Fulgent Genetics seller in Q1 2026 was Millennium Management, an estimated $11.7M sold.

Based on aggregated 13F filings for Q1 2026.